about
The EGLN-HIF O2-Sensing System: Multiple Inputs and Feedbacks.Epigenome Aberrations: Emerging Driving Factors of the Clear Cell Renal Cell Carcinoma.Crosstalk between VEGFR and other receptor tyrosine kinases for TKI therapy of metastatic renal cell carcinoma.Hypoxia-Inducible Factor 2-Dependent Pathways Driving Von Hippel-Lindau-Deficient Renal Cancer.SINHCAF/FAM60A and SIN3A specifically repress HIF-2α expression.
P2860
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Targeting HIF2 in Clear Cell Renal Cell Carcinoma.
@en
Targeting HIF2 in Clear Cell Renal Cell Carcinoma.
@nl
type
label
Targeting HIF2 in Clear Cell Renal Cell Carcinoma.
@en
Targeting HIF2 in Clear Cell Renal Cell Carcinoma.
@nl
prefLabel
Targeting HIF2 in Clear Cell Renal Cell Carcinoma.
@en
Targeting HIF2 in Clear Cell Renal Cell Carcinoma.
@nl
P2860
P1476
Targeting HIF2 in Clear Cell Renal Cell Carcinoma.
@en
P2093
Hyejin Cho
P2860
P304
P356
10.1101/SQB.2016.81.030833
P577
2016-12-08T00:00:00Z